U.S. Markets closed

Idera Pharmaceuticals, Inc. (IDRA)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.67-0.01 (-0.60%)
At close: 4:00PM EDT

1.67 0.00 (0.00%)
After hours: 4:00PM EDT

People also watch
CPRXFOLDHALOSGYPGALE
Interactive chart
Previous Close1.68
Open1.72
Bid1.66 x 100
Ask1.70 x 100
Day's Range1.66 - 1.72
52 Week Range1.30 - 3.33
Volume504,203
Avg. Volume1,716,569
Market Cap249.08M
Beta2.15
PE Ratio (TTM)-5.53
EPS (TTM)-0.3
Earnings DateJul 31, 2017 - Aug 4, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.75
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    ETFs with exposure to Idera Pharmaceuticals, Inc. : May 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Idera Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IDRA-US. Comparing the performance and risk of Idera Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube14 days ago

    ETFs with exposure to Idera Pharmaceuticals, Inc. : May 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Idera Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IDRA-US. Comparing the performance and risk of Idera Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Idera Pharmaceuticals, Inc. :IDRA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
    Capital Cube15 days ago

    Idera Pharmaceuticals, Inc. :IDRA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017

    Categories: Yahoo FinanceGet free summary analysis Idera Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Idera Pharmaceuticals, Inc. – Dynavax Technologies Corporation, Amgen Inc., Agenus Inc., Abbott Laboratories, Merck & Co., Inc., Biogen Inc. and Pfizer Inc. (DVAX-US, AMGN-US, AGEN-US, ABT-US, MRK-US, BIIB-US ... Read more (Read more...)